- Sputnik International, 1920
World
Get the latest news from around the world, live coverage, off-beat stories, features and analysis.

Argentine President Says Had Mild Form of COVID-19 Thanks to Russia's Sputnik V Vaccine

© AFP 2023 / ESTEBAN COLLAZOHandout picture released by Argentina's Presidency showing Argentine President Alberto Fernandez announcing new measures against the spread of the novel coronavirus, COVID-19, from Olivos Presidential Residence in Olivos, Buenos Aires, on April 14, 2021.
Handout picture released by Argentina's Presidency showing Argentine President Alberto Fernandez announcing new measures against the spread of the novel coronavirus, COVID-19, from Olivos Presidential Residence in Olivos, Buenos Aires, on April 14, 2021. - Sputnik International, 1920, 15.04.2021
Subscribe
BUENOS AIRES (Sputnik) – Argentine President Alberto Fernandez said that he had a mild form of COVID-19 thanks to the vaccination with Russia's Sputnik V drug.

"I managed to bear [the illness] well due to the vaccine I got," Fernandez said in an address to the Argentine people.

Fernandez tested positive for COVID-19 on April 3, soon after being vaccinated with Sputnik V on on January 21. On the same day, doctors assessed the president's health as stable.

A Palestinian health worker displays a vial of Russia's Sputnik V vaccine in Gaza City February 24, 2021. - Sputnik International, 1920, 13.04.2021
World
Argentine Scientists Say One Dose of Russia's Sputnik V Develops High Immune Response
According to Argentine newspaper Clarin, the president has been inoculated with the second dose of the vaccine as well.

All this time, the president has continued to work, holding meetings in the virtual format. The day before, he even dined online with US National Security Council Senior Director for Western Hemisphere Affairs Juan Gonzalez.

The president's medical team said on Wednesday that Fernandez would return to work on Thursday.

Sputnik V has already been authorized in at least 60 countries with a total population of about 3 billion people. Sputnik V ranks second globally in terms of the number of approvals received by government regulators. The vaccine efficacy at 91.6 percent is confirmed by the publication of data in high-profile medical journal The Lancet.
Newsfeed
0
To participate in the discussion
log in or register
loader
Chats
Заголовок открываемого материала